1. Home
  2. SPRO vs IPWR Comparison

SPRO vs IPWR Comparison

Compare SPRO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • IPWR
  • Stock Information
  • Founded
  • SPRO 2013
  • IPWR 2007
  • Country
  • SPRO United States
  • IPWR United States
  • Employees
  • SPRO N/A
  • IPWR N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • IPWR Industrial Machinery/Components
  • Sector
  • SPRO Health Care
  • IPWR Industrials
  • Exchange
  • SPRO Nasdaq
  • IPWR Nasdaq
  • Market Cap
  • SPRO 45.7M
  • IPWR 39.9M
  • IPO Year
  • SPRO 2017
  • IPWR 2013
  • Fundamental
  • Price
  • SPRO $0.72
  • IPWR $5.31
  • Analyst Decision
  • SPRO Buy
  • IPWR Hold
  • Analyst Count
  • SPRO 4
  • IPWR 1
  • Target Price
  • SPRO $5.00
  • IPWR $5.05
  • AVG Volume (30 Days)
  • SPRO 118.7K
  • IPWR 19.4K
  • Earning Date
  • SPRO 03-27-2025
  • IPWR 05-14-2025
  • Dividend Yield
  • SPRO N/A
  • IPWR N/A
  • EPS Growth
  • SPRO N/A
  • IPWR N/A
  • EPS
  • SPRO N/A
  • IPWR N/A
  • Revenue
  • SPRO $47,977,000.00
  • IPWR $86,032.00
  • Revenue This Year
  • SPRO N/A
  • IPWR $11,756.05
  • Revenue Next Year
  • SPRO N/A
  • IPWR N/A
  • P/E Ratio
  • SPRO N/A
  • IPWR N/A
  • Revenue Growth
  • SPRO N/A
  • IPWR N/A
  • 52 Week Low
  • SPRO $0.70
  • IPWR $4.57
  • 52 Week High
  • SPRO $1.81
  • IPWR $9.69
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 38.19
  • IPWR 49.38
  • Support Level
  • SPRO $0.75
  • IPWR $5.00
  • Resistance Level
  • SPRO $0.80
  • IPWR $5.44
  • Average True Range (ATR)
  • SPRO 0.05
  • IPWR 0.24
  • MACD
  • SPRO 0.00
  • IPWR 0.11
  • Stochastic Oscillator
  • SPRO 9.09
  • IPWR 81.93

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: